Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Return on Capital Employed (2016 - 2024)

Trinity Biotech's Return on Capital Employed history spans 16 years, with the latest figure at 31.0% for Q4 2024.

  • On a quarterly basis, Return on Capital Employed rose 2720.0% to 31.0% in Q4 2024 year-over-year; TTM through Dec 2024 was 31.0%, a 2720.0% increase, with the full-year FY2025 number at 42.69%, up 8565.0% from a year prior.
  • Return on Capital Employed hit 31.0% in Q4 2024 for Trinity Biotech, down from 19.79% in the prior quarter.
  • Over the last five years, Return on Capital Employed for TRIB hit a ceiling of 86.72% in Q2 2021 and a floor of 58.2% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 5.08% across 5 years, with a median of 5.91% in 2022.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 8204bps in 2021 and later tumbled -8644bps in 2022.
  • Tracing TRIB's Return on Capital Employed over 5 years: stood at 19.16% in 2020, then surged by 70bps to 32.57% in 2021, then crashed by -177bps to 24.92% in 2022, then tumbled by -134bps to 58.2% in 2023, then skyrocketed by 47bps to 31.0% in 2024.
  • Business Quant data shows Return on Capital Employed for TRIB at 31.0% in Q4 2024, 19.79% in Q3 2024, and 23.09% in Q2 2024.